The official said it was not possible to share the quantum of premium price hike sought as it depends on the regulator, adding approvals generally come within a month.
The allotment to the joint venture partner MSI is in consideration for the transfer of equity shares constituting 20.57 per cent of the paid-up share capital of Max Life held by it to MFSL.